Document:

Exhibit 10.10

 

PURCHASE
AND SALE AGREEMENT

 

THIS
CONTRACT (“Contract”) is entered into between ONCE LOWLY LOT, LLC, an Oklahoma limited liability company (“Seller”),
and AGRO CAPITAL MANAGEMENT CORPORATION, a publicly traded corporation organized under the laws of the State of Nevada (“Buyer”).
Hereinafter, Seller and Buyer may be individually referred to as “Party” and collectively referred to as the “Parties.”

 

Upon
execution of this Contract by the Parties, evidenced by their signatures hereto, a valid and binding contract of sale shall exist. The
“Effective Date” hereof shall be the _____ day of June, 2021. The terms and conditions shall be as follows:

 

1.
SALE: Seller agrees to sell and convey to Buyer by General Warranty Deed (hereinafter, the “Deed”), and Buyer agrees
to purchase, the real estate located at 1814 NW 1st Street, Oklahoma City, Oklahoma 73106-3008, together with any improvements thereon
(collectively the “Property”), if any, which such Property may be further described as:

 

CARLE
& COLCORD ADDITION 013 000 W1/2 OF LOT 4 & LOTS 5 THRU 8

 

The
exact size and legal description of the Property shall be determined by a survey, as provided herein.

 

2.
PURCHASE:

 

(a)
Consideration. As consideration for Seller’s sale, disposition, and transfer of the Property to Buyer, Buyer shall set aside
for Seller, whether in escrow, in trust, or otherwise separate from the assets of Buyer, five hundred thousand (500,000) restricted shares
of Buyer’s common stock (the “Shares”). Buyer’s interest in the Shares shall vest at the end of the second anniversary
of the Effective Date of this Agreement, upon which time Buyer will obtain full rights thereto, including the right to resell such Shares.

 

(b)
Vesting. Unless otherwise expressly agreed to by the Parties in writing, the Shares set aside for Seller shall vest in full on
the second anniversary of the Effective Date of this Agreement (the “Vesting Date”), provided that such vesting shall not
occur upon the Seller’s failure to upgrade the Property in accordance with this agreement (“Termination”). If Seller
voluntarily or involuntarily affects a Termination for any reason (including due to death, disability, or otherwise) prior to the Vesting
Date, Buyer shall automatically reacquire all Shares and/or Bonus Shares that have not yet vested in accordance with this provision.

 

(c)
Rights in Unvested Shares. Prior to the Vesting Date, Seller shall have all rights and privileges of a shareholder of Buyer with
respect to the Shares set aside and otherwise unvested, except that Seller may not resale, dispose of, gift, assign, or otherwise transfer
such Shares unless Buyer agrees to such transfer in writing. Buyer shall have no right to sell, grant, assign, dispose of, or otherwise
transfer unvested Shares set aside for the benefit of Seller.

 

(d)
Delivery of Shares. The full number of Shares contemplated for payment to Seller under this Agreement shall be set aside for the
benefit of Seller in accordance with Section 2(a) above, in full upon delivery of the Deed at Closing.

 

    	1

    	 

    

 

3.
SURVEY: If a survey is available and in the possession or control of Seller, it shall be provided to Buyer within ten (10) days
of the Effective Date. Within sixty (60) days from the Effective Date, Buyer shall cause an updated survey to be prepared the (“Survey”). 
The Survey shall comply with the minimum standard detail requirements for land title surveys as adopted by ALTA/ACSM.

 

4.
SELLER UPGRADES: Upon the date of Closing, Seller shall provide for certain improvements and upgrades to the Property (“Improvements”),
and Seller shall solely assume the complete costs thereof, including the following improvements:

 

	 	(i)	upgrading
    the Property’s electrical service to 400-AMP;
	 	(ii)	installing,
    or providing for the installation of, a 480 Volt 3 Phase power system.
	 	(iii)	installing
    a security camera and monitoring system which meets both (i) relevant State legal requirements; and (ii) is compatible with Buyer’s
    offsite monitoring needs.

 

5.
TAXES AND PRORATIONS:

 

(a)
The Seller shall pay in full:

 

(i)
all special assessments against the Property upon the date of Closing, whether or not payable in installments;

(ii)
all taxes which are a lien on the Property upon the date of Closing;

(iii)
the cost of any item of workmanship or material furnished on or prior to the date of Closing, including utility charges, which is or
may become a lien on the Property; and

(iv)
the cost of all improvements or upgrades contemplated herein in connection with the sale of the Property.

 

(b)
The following items shall be prorated between the Seller and Buyer as of the date of Closing:

 

(i)
rents, if any; and

(ii)
general ad valorem taxes for the current calendar year, provided that, if the amount of such taxes has not then been fixed, the proration
shall be based upon the rate of levy for the previous calendar year.

 

6.
RISK OF LOSS: Until Closing, the Seller shall bare the risk of loss to the Property.

 

7.
SELLER’S REPRESENTATIONS: Seller’s representations are as follows:

 

(a)
There are no contracts or other obligations outstanding for the sale, exchange, or transfer of all or any part of the Property other
than this Contract.

 

    	2

    	 

    

 

(b)
There are no sites of historical or archaeological importance on the Property, which in any way would impede, curtail, limit, or restrict
the development of the Property.

 

(c)
Seller shall not at any time prior to Closing grant to any person an interest in the Property.

 

(d)
Seller has:

 

(i)
all requisite power and authority:

 

(1)
to own its property and operate its business, and

(2)
to enter into this Contract and consummate the sale contemplated in this Contract, and

 

(ii)
by proper action, duly authorized the execution and delivery of this Contract and the consummation of the sale contemplated in this
Contract.

 

(e)
At or prior to the Closing, any existing leases covering the Property shall be fully terminated and any existing tenants of the Property,
other than Buyers shall have fully vacated the Property, unless otherwise agreed to by the Parties.

 

(f)
The Seller’s execution of this Contract and consummation of the sale do not and will not result in a breach of or constitute a
default under the terms of provisions of any indenture, agreement, instrument or obligation to which the Seller is a party or by which
the Property or any portion thereof is bound.

 

(g)
Seller is the owner of good marketable fee simple title to the Property, free and clear of any liens, deeds of trust, pledges, leases,
charges, encumbrances, joint ownerships, or restrictions of any kind, except liens to be discharged at or prior to Closing.

 

(h)
Seller shall, upon the date of Closing and for as long as necessary thereafter, assist Buyer in obtaining an Oklahoma Medical Marijuana
Authority (OMMA) manufacturing license, and provide the requisite funds for obtaining such license.

 

9.
CONDEMNATION: If, prior to the Closing, action is initiated or threatened to take a material portion of the Property by eminent
domain proceedings, or by deed in lieu thereof, for any portion of the Property, Buyer may either

 

(a)
Terminate this Contract; or

 

(b)
Close the sale and the entire award of the condemning authority will be assigned by Seller to Buyer at the Closing.

 

    	3

    	 

    

 

10.
CLOSING: The Closing shall take place at _____________________________ no later than June 30, 2021, after the satisfaction of
all contingencies hereto; however, if, at the option of the Seller, the Closing occurs prior to June 30, 2021, any remaining obligation
of the Buyers under any other oral or written agreement with Seller whatsoever, will end and any amounts owed be prorated to the date
of the Closing.

 

11.
SELLER DELIVERY AT CLOSING: At Closing, Seller shall deliver or cause to be delivered to Buyer, at Seller’s sole cost and
expense, each of the following:

 

(a)
The Deed duly executed and acknowledged by Seller.

 

(b)
All additional documents and instruments as, in the mutual and reasonable opinion of Seller’s and Buyer’s counsel, are reasonably
necessary for the proper consummation of this transaction.

 

12.
BUYER’S DELIVERY AT CLOSING: At the Closing, Buyer, at Buyer’s sole cost and expense, shall deliver to Seller the
following:

 

(a)
The Shares in the amount and manner required by Section 2(a)–(d) herein.

 

(b)
All additional documents and instruments as, in the mutual and reasonable opinion of Seller’s and Buyer’s counsel, are reasonably
necessary for the proper consummation of this transaction.

 

13.
NO PARTNERSHIP: Nothing herein is intended to create any relationship other than Buyer and Seller in an arms-length transaction.
By this agreement, these parties do not intend to create any partnership, joint venture, association, or any such similar relationship,
all of which are herein specifically denied.

 

14.
FINAL LEGAL DESCRIPTION: In the event the preliminary legal description of the Property is different from that contained in the
Survey prepared in accordance with this Contract, the final legal description of the Property (the “Final Legal Description”)
will be the one specified on the Survey, and once approved by Buyer and Seller, the Final Legal Description shall be substituted for
the preliminary legal description of the Property contained in Section 1 and this Contract shall be deemed amended by such substitution
without the necessity of the parties executing any further amendment to this Contract. Upon such substitution, the real estate portion
of the Property shall be thereafter defined as set forth in the Final Legal Description.

 

15.
COMMISSIONS : Purchaser and Seller covenant and represent to each other that no other party is entitled to be paid a fee
or commission in connection with the transaction contemplated by this Agreement, and neither Purchaser nor Seller has had any dealings
or agreements with any other individual or entity in connection therewith. If any other individual or entity will assert a claim to a
finder’s fee, or commission, or other similar fee against either Purchaser or Seller on account of an alleged employment, arrangement
or contract as a broker or a finder, then the party who is alleged to have retained such individual or entity will and does hereby agree
to indemnify and hold harmless the other party from and against any such claim and all costs, expenses, liabilities and damages incurred
in connection with such claim or any action or proceeding brought thereon. Seller agrees that in the event and only in the event the
transaction contemplated by this Agreement is consummated, then, at the Closing, Seller will pay a real estate commission to the Broker
in accordance with a separate agreement at Closing.

 

    	4

    	 

    

 

16.
NOTICES: All notices required under this Contract shall be deemed to be properly served if reduced to writing and sent by (i)
certified or registered mail; (ii) Federal Express or similar overnight courier; (iii) facsimile transmission; or (iv) personal delivery
and the date of such notice will be deemed to have been the date on which such notice is delivered or attempted to be delivered as shown
by the certified mail return receipt or a commercial delivery service record, or in the case of facsimile on the date of receipt of the
transmission as shown on a successful transmission confirmation receipt. All notices shall be addressed as follows, unless otherwise
specified in writing:

 

To
Buyer:

 

3651
Lindell Road, Suite D430,

Las
Vegas, Nevada 89103

 

With
Notice To:

 

Overman
Legal Group

809
NW 36th St.

Oklahoma
City, OK 73118

 

To
Seller:

 

[17504 Egrets Ldg, Edmond,
OK 73012]

 

With
Notice To:

 

Jacquelyn L. Dill

[The Dill Law Firm,
12101 N. MacArthur Blvd. Suite 200, Oklahoma City, OK 73162] 

 

17.
LEGAL FEES: If either Buyer or Seller brings any action or suit against the other for any matter relating to or arising out of
this Contract then the prevailing party in such action, suit or proceeding, whether by final judgment or out of court settlement, shall
be entitled to recover from the other party all costs and expenses of suit, including actual reasonable attorneys’ fees.

 

18.
EFFECT: This Contract, when executed by both Seller and Buyer, shall be binding upon and inure to the benefit of Seller and Buyer,
their respective heirs, legal representatives, successors and assigns.

 

19.
ENTIRETY: This Contract sets forth the complete understanding of Seller and Buyer with respect to the matters set forth herein
and supersedes all previous negotiations, representations and agreements between them and their employees, agents and representatives.

 

20.
AMENDMENT: This Contract can only be amended or modified by a written agreement signed by Seller and Buyer.

 

    	5

    	 

    

 

21.
CONSENTS: Whenever the consent of Seller or Buyer is required hereunder, such consent, unless herein committed to such party’s
sole discretion, will not be unreasonably withheld or delayed.

 

22.
CONFIDENTIALITY: Seller and Buyer agree to keep this Contract and the terms and provisions thereof confidential and not to make
any public announcement or disclosure or provide any third party any information or facts; including, but not limited to, the Purchase
Price, without the written consent of the other party. The provisions of this Paragraph shall survive Closing.

 

24.
1031 EXCHANGE . It is the intent of the parties to consummate this transaction in manner, which will allow each party to
effectuate a tax deferred exchange under Section 1031 of the Internal Revenue Code of 1986, as amended. The parties agree to cooperate
with the other parties to effectuate a tax deferred exchange, provided that the cooperating party incurs no additional cost or expense,
and provided further that the party requesting such cooperation indemnifies and holds the cooperating party and its affiliates harmless
from and against any and all claims, demands, judgment, costs and expenses, including reasonable attorney’s fees and costs, associated
with such cooperating party’s cooperation with such tax-free exchange; which indemnification shall survive closing of this transaction.
All costs and expenses associated with such tax-free exchange shall be borne solely by the party requesting such cooperation and shall
be reimbursed to the cooperating party at closing, including but not limited to, any additional attorneys’ fees, which the cooperating
party incurs in connection with such tax deferred exchange.

 

25.
TIME OF ESSENCE: This Contract shall be null and void unless signed by Seller and delivered to Buyer on or before 5:00 P.M., _____________________,
2021. Time is of the essence of this Contract and Buyer and Seller hereby agree to perform each and every obligation hereunder in a prompt
and timely manner; provided however, that if the date for the performance of any action or obligation, or any time period specified here
under occurs on a Saturday, Sunday or United States bank holiday, then such date or time period shall be extended until the next business
day.

 

26.
INSURANCE: The Seller and Buyer agree that, to the extent such contract for insurance is assignable, Buyer will assume responsibility
for payment of premiums on any insurance policy for casualty or loss currently in effect, offering coverage for the Property. To the
extent Seller is named as an “Insured” or “Additional Insured” with respect to the Property, Seller and Buyer
agree that such insurance coverage will be maintained to the benefit of Buyer. Seller agrees that it will not make any claim on any insurance
policy respecting the Property following the date of execution below.

 

27.
ASSIGNMENT. The Seller and Buyer agree that Buyer may assign its interest in this Contract. At any date following the date of
execution below, Buyer can exercise any and all rights of assignment to any other entity, person, individual, third party, company, corporation,
partnership, limited liability company, or lawful entity regardless of ownership, control or any other consideration.

 

    	6

    	 

    

 

EXECUTED
this 30 day of June, 2021.

 

	“SELLER”
    	Once
    Lowly Lot, LLC
	 	 	 
	 	By:
    	/s/
    Michael B. Yowell
	 	Name: 	Michael
    B. Yowell
	 	Title:	President
	 	 	 
	“BUYER”	Agro
    Capital Management Corporation
	 	 	 
	 	By:
    	/s/
Ted Hicks
	 	Name:	Ted
    Hicks
	 	Title:	President

 

CLOSING
COMPANY ACKNOWLEDGMENT:

 

Receipt
of this Contract executed by Buyer and Seller is acknowledged by the undersigned this _______ day of June, 2021.

 

	 	By:
    	 
	 	Name: 
    	 
	 	Title:	 

 

    	7Exhibit 10.1

 

EMPLOYMENT
AGREEMENT

 

This Employment
Agreement (this “Agreement”) is entered by and between Longeveron, INC, a Delaware Corporation with
offices located at 1951 NW 7th Ave., Ste. 520, Miami, Florida 33136 (the “Company”), and Dr. Chris Min,
an individual with a legal address of 305 E. 85th St., New York, NY 10028 (the “Executive”), as of the date(s)
set forth on the signature page(s) hereto (the “Effective Date”).

 

WHEREAS, the
Company and the Executive desire to enter into this Agreement and to enter into or continue the employment of Executive upon the terms
and conditions set forth herein;

 

WHEREAS, Executive
acknowledges that during his employment with the Company, the Executive will have access to certain confidential, proprietary information
and trade secrets belonging to the Company’s existing and future business and that Executive has an obligation not to disclose,
misappropriate, use for his own personal or a third party’s purposes and/or unfairly benefit from the Company’s confidential,
proprietary, information, trade secrets, customers, prospective customers and good will;

 

NOW, THEREFORE,
intending to be legally bound, and for good and valuable consideration, the Company and Executive hereby agree as follows:

 

1. Reaffirmation
of Recitals. The foregoing recitals are complete, true and correct and are incorporated herein and made part hereof by this reference.
Executive acknowledges the Company’s reliance thereon as a material inducement to enter into this Agreement.

 

2. Term.
Subject to Section 5 below, the term of this Agreement shall be one (1) year commencing on the date of this Agreement (the “Initial
Term”). After the Initial Term, this Agreement shall be automatically renewed for successive one (1) year periods (each a “Renewed
Term”), unless, at least sixty (60) days prior to the end of the Initial Term or a Renewed Term, either party delivers written
notice to the other that the Agreement is not to be renewed, in which case, the Agreement and Executive’s employment hereunder shall
be terminated as of the end of the applicable Initial Term or Renewed Term. The Initial Term and any Renewed Term shall be collectively
referred to as the “Term.”

 

3.
Position and Duties.

 

(a)
During the Term, Executive shall be employed as the Chief Medical Officer (“CMO”), and shall report to the Chief
Executive Officer (“CEO”) or his designee ( such as the Chief Science Officer or “CSO” or some other
designee with a science/medical background). Executive shall have such duties and responsibilities as are reasonably commensurate
with Executive’s position, including those duties specified in the attached Schedule A, and such other duties and
responsibilities as the CEO or his designee may reasonably assign to Executive from time to time. Executive shall devote
Executive’s working time to the fulfillment of Executive’s duties and responsibilities under this Agreement, and
Executive shall perform such duties and responsibilities to the best of Executive’s abilities, and in a trustworthy,
businesslike and efficient manner. Executive shall not be actively involved in any other trade or business that, in the reasonable
opinion of the Company, would be considered a conflict of interest or direct competition to Company, or as an Executive of any other
such trade or business. Executive shall at all times comply with and be subject to such policies and procedures as the Company may
establish or change from time to time (“Policies”); provided, however, that in the event of a conflict between
the terms of this Agreement and the provisions of any such Policies, the terms of this Agreement shall control and provided further
that all Policies must be reduced to a writing and provided to the Executive..

 

     

     

    

 

(b) Executive
acknowledges and agrees that Executive owes a fiduciary duty of loyalty, fidelity, and allegiance to act at all times in the best interests
of the Company and to do no act which Executive reasonably should know would injure the Company’s business, interests, or reputation.
In keeping with Executive’s fiduciary duties to the Company, Executive agrees that Executive shall not become involved in a conflict
of interest with the Company, or upon discovery thereof, allow such a conflict to continue. Moreover, Executive shall not engage in any
activity that might involve a possible conflict of interest without first obtaining approval in accordance with the Company’s Policies.

 

(c) The
Company recognizes that Executive may, without violating this Agreement, engage in or continue to engage in outside activities that do
not involve a conflict of interest, such as serving on community boards or the boards of professional or trade organizations, volunteering
for community organizations or professional or trade organizations, managing personal investments, engaging (to an extent that does not
interfere with Executive’s performance of his duties) in business ventures that do not involve a conflict of interest, or engaging
in charitable or not-for-profit activities.

 

(d) Company’s
office is presently located at Life Science & Technology Park, 1951 NW 7th Avenue, Suite 520, Miami, FL 33136, and Executive may be
required to be present at this or some other future work location from time to time for those work requirements that reasonably require
Executive’s in-person attendance. Notwithstanding the foregoing, it is understood that as a general matter, Executive is permitted
to and shall perform Executive’s duties remotely in Executive’s discretion. Executive’s duties also shall include travel
reasonably commensurate with Executive’s position.

 

4. Compensation and Benefits. During
the Term, Executive shall receive the following compensation:

 

(a) Base
Salary. The Company shall pay Executive an annual salary of three- hundred and fifty thousand dollars ($350,000.00) (the “Base
Salary”), paid in accordance with the Company’s normal payroll practices (subject to appropriate tax and other withholdings).
Executive’s Base Salary will be subject to annual review and adjustment by the CEO and/or the Compensation Committee of the Board
of Directors (“Compensation Committee”).

 

(b) Annual
Bonus & One-Time Signing Bonus. Executive will also be eligible to receive an annual bonus of thirty percent (30%) of the
then Base Salary, based on written metrics established and agreed to each year between Executive and CEO and/or the Compensation
Committee. Annual Bonus will be due no later than January 31st of each year (and shall be prorated for partial years).
Executive’s Annual Bonus may be suspended or reduced, along with the bonuses of all other Company Executives, if in the sole
discretion of the Board such action is necessary to safeguard the financial interests of the Company. In addition to the annual
bonus as recited above, Executive shall be entitled to a one-time signing bonus of $30,000 in value of Restricted Stock Units and
$30,000 in value of stock options (valued based on the closing price of the Company’s common stock on Executive’s
starting date). 50% of this signing bonus shall vest after the signing of this Agreement upon commencement of employment, and the
remaining 50% shall vest on January 1, 2023.

 

    2

     

    

 

(c) Initial
Equity Grant and Annual Equity Grants. Executive will receive 150,000 Restricted Stock Units (“RSUs”) and 50,000
Stock Options, all vesting over a four (4) year period commencing with Executive’s employment, such that 25% of these grants shall
vest upon the one-year anniversary of Executive’s employment with Company, and an additional 25% shall vest on the two-year, three-year,
and four-year anniversaries, respectively. Executive may also be granted additional equity (“Equity”) in the Company in the
future in accordance with, and subject to the terms and conditions of the Company’s Plan and Option Award Agreement as determined
by the CEO and/or Compensation Committee.

 

(d) Vacation.
Executive shall be entitled to twenty (20) days of paid vacation per year (prorated for partial years), to be taken at times mutually
acceptable to Executive and the Company, and to such paid holidays as are observed by the Company. Paid vacation that is not used in a
year will roll-over to the following year in accordance with Company Policies. For purposes of this Section 4(d), the word “year”
means the twelve (12) month period the Company uses administratively for purposes of vacation records.

 

(e) Welfare
and Retirement Benefits. Executive shall be eligible to participate in each of the Company’s Executive benefit plans and programs,
in accordance with the terms thereof and as they may be changed from time to time, that the Company offers to similarly situated Executives,
if any, for so long as the Company shall continue to offer said plans and programs, and subject to Executive’s payment of any required
contributions. Notwithstanding any provision of this Agreement to the contrary, nothing contained herein shall be construed to limit,
condition, or otherwise encumber the rights of the Company, in its sole discretion, to amend, discontinue, substitute or maintain any
benefit plan, program, or perquisite applicable to Executives of the Company generally.

 

(f) Tax
Withholding. The Company shall withhold from any compensation, benefits or amounts payable under this Agreement all federal, state,
city or other taxes as may be required pursuant to any law or governmental regulation or ruling. Except where the Company is so required
to withhold and remit any such taxes, Executive shall be responsible for any and all federal, state, city or other taxes that arise out
of any compensation, benefits or amounts payable to Executive hereunder.

 

(g) Expenses.
During the Term, and subject to the provisions of Section 21(d) of this Agreement, Executive shall be entitled to receive prompt reimbursement
for all reasonable and documented business expenses, including travel expenses to and from and on behalf of Company, that Executive incurs
in accordance with the policies and procedures established by the Company from time to time, provided that Executive properly accounts
therefor in accordance with Company policy, as may be amended from time to time.

 

    3

     

    

 

5.
Termination and Termination Compensation.

 

(a) General.
This Agreement and Executive’s employment with the Company hereunder shall be terminated prior to the end of the Term in accordance
with the provisions of this Section 5: (i) automatically upon Executive’s death, (ii) at any time by the Company in the event of
Executive’s Disability, (iii) at any time by the Company upon written notice to Executive for Cause, (iv) voluntarily at any time
by Executive or the Company upon sixty (60) days’ advance written notice to the other, or (v) at any time by Executive for Good
Reason.

 

 (b) Definitions. For purposes of this Agreement:

 

(i) “Cause”
means, as determined by the Company: (A) the commission by Executive of an act of theft, fraud, embezzlement, falsification of the Company
or customer documents, misappropriation of funds or other assets of the Company or its affiliates, involving the property or affairs of
the Company or its affiliates; (B) the conviction of Executive (by trial, upon a plea or otherwise) or the admission of guilt or a plea
of nolo contender by Executive, of any felony or criminal act of moral turpitude; (C) the failure of Executive to substantially perform
his material duties or responsibilities under this Agreement, or follow the reasonable instructions of the Company regarding a matter
material to the Company, provided that if such failure is reasonably capable of cure, Executive is given written notice of any such failure,
which notice shall specify in reasonable detail the nature of the failure to substantially perform, and Executive fails to remedy the
same within thirty (30) days of receipt of such notice; (D) the material breach by Executive of any material provision of this Agreement,
or of any fiduciary duty to the Company or material violation of any other material contractual, statutory, common law or other legal
duty to the Company or its affiliates; (E) gross negligence or willful misconduct by Executive in the performance of Executive’s
duties; (F) Executive’s material violation of any material written policy or procedure of the Company, provided that if such violation
is capable of cure in the Company’s reasonable determination, Executive is given written notice of any such violation, which notice
shall specify in reasonable detail the nature of the violation, and Executive fails to remedy the same within thirty (30) days of receipt
of such notice; or (G) conduct that brings the Company into public disgrace or disrepute in any material respect.

 

(ii)
“Disability” means, if the Company or any of its affiliates sponsors a long-term disability plan that covers
Executive, the standard such long-term disability plan uses to determine a participant’s eligibility for benefits, provided,
that the long-term disability insurer had accepted Executive’s claim, and provided further, that Executive’s
incapacity is likely to be continuous for at least six (6) months or be permanent. If Executive is not covered by such a long- term
disability plan, however, then “Disability” means Executive becomes physically or mentally incapacitated so as to be
unable to perform the essential function of Executive’s job, with or without a reasonable accommodation, and such incapacity
is likely to be continuous for at least six (6) months or be permanent. Any disputes as to whether Executive meets the standard of
Disability set forth herein shall be resolved initially through consultation between Executive’s treating physician and a
physician retained by the Company (collectively the “Treating Physicians”). If the Treating Physicians cannot
agree, then the Treating Physicians shall select an independent physician who is a recognized specialist in the condition(s) causing
the incapacity, who shall render a binding determination as to Disability after full consultation with the Treating Physicians,
examination of any relevant medical records, and reviewing the results of relevant medical tests.

 

    4

     

    

 

(iii) “Good
Reason” means, without Executive’s express written consent, a material diminution in Executive’s authority, duties,
or responsibilities (excluding any change made in connection with the
termination of Executive’s employment for Cause, or on account of Executive’s death or Disability, or temporarily as a result
of Executive’s incapacity or other absence for an extended period);
a change in the geographic location where Executive must regularly render services by more than 25 miles miles, provided that any such
relocation materially increases the length of Executive’s normal daily work commute; or a material breach of this Agreement by the
Company. In order for Executive to resign for Good Reason: (A) the Company must be notified by Executive in writing of the event constituting
Good Reason; (B) if capable of cure in the reasonable determination of Executive, the event must remain uncorrected by the Company for
thirty (30) days following such notice (the “Company Notice Period”); and (C) if the Company fails to cure the same
during the Company Notice Period, then the termination must occur within sixty (60) days after the expiration of the Company Notice Period.
Notwithstanding the foregoing, an across-the-board salary reduction affecting Executive and other similarly situated Executives of the
Company shall not constitute Good Reason.

 

(c) Termination
by the Company for Cause or as a result of Death or Disability; Resignation by Executive without Good Reason; and Nonrenewal of a Term.

 

(i) If
the Company terminates this Agreement and Executive’s employment hereunder for Cause, if this Agreement and Executive’s employment
hereunder are terminated because of Executive’s death or Disability, if Executive terminates this Agreement and his employment hereunder
without Good Reason, or the Agreement and Executive’s employment hereunder is not renewed at the expiration of the Term, Executive
shall be entitled to receive the following compensation (collectively, the “Accrued Rights”):

 

 (A) the Base Salary through the date of termination;

 

 (B) payment for any earned but unused vacation time (as described in Section 4(d));

 

 (C) such welfare and retirement benefits, if any, as to which Executive may be entitled under the terms thereof (as described in Section 4(e)); and

 

 (D) such reimbursable business expenses as may be due and owing to Executive under Section 4(g), provided Executive submits a claim for such expenses within thirty (30) days after Executive’s employment is terminated.

 

(ii) The
amount due under Section 5(c)(i)(A) and (B) shall be paid in a lump sum on the first regular payday following the date of Executive’s
termination (or sooner if required by law). The amount due under Section 5(c)(i)(C) shall be paid in accordance with the terms of the
plans that provide those benefits. The amount due under Section 5(c)(i)(D) shall be paid in accordance with time period set forth in Section
4(g).

 

    5

     

    

 

(d) Termination by the Company without Cause
or by Executive for Good Reason.

 

(i) If the Company terminates this
Agreement and Executive’s employment hereunder without Cause (other than by reason of Disability), or if Executive terminates
this Agreement and Executive’s employment hereunder for Good Reason, Executive shall receive only the following
compensation:

 

 (A) The Accrued Rights; and

 

 (B) A severance benefit equal to 3 months of the then existing Base Salary for every year Executive remains employed with Longeveron, capped at 12 months. (in all cases assuming no for cause termination or voluntary resignation. Severance benefit payment shall be made in one lump sum payment or, at the Company’s discretion, in equal installments, at least monthly, in accordance with the Company’s established payroll procedures, beginning after the release referred to in Section 5(d)(ii) becomes effective, but in no event later than the sixtieth (60th) day following Executive’s termination date. The first such payment shall include payment of all amounts of severance pay that otherwise would have been due prior to such date, applied as though such payments commenced on the next normal pay date immediately following Executive’s termination date; and

 

(C) Any
unvested stock options, restricted stock, or other equity- based compensation that has been granted to Executive will vest immediately.

 

(D) If Executive timely elects
to continue health benefits coverage under COBRA, the Company will reimburse Executive, subject to the provisions of Section 21(d) of
this Agreement, the amount of the COBRA premiums paid for the initial three (3) months of COBRA continuation coverage.

 

(ii) As
a condition to the receipt of the severance benefits set forth in clause (i)(B) and (C) of this Section 5(d), Executive must (A)
execute and not timely revoke Company’s release, substantially in the form attached hereto as Exhibit A within twenty-one (21) days
after Executive’s employment is terminated (within forty-five (45) days after Executive’s employment is terminated in the
case of a group termination), and (B) Executive must continue to comply with Executive’s obligations under Sections 5(g), 6, 7,
8, and 9 of this Agreement.

 

(iii) Executive
shall not be under any duty or obligation to seek or accept other employment following a termination of employment pursuant to which a
severance benefit payment under this Section 5 is owing and the amounts due to Executive pursuant to Section 5 shall not be reduced or
suspended if Executive accepts subsequent employment or earns any amounts as a self-employed individual, provided that in the event Executive
materially breaches any of Executive’s obligations under Section 6, 7, 8 or 9 of this Agreement, then, in addition to the Company’s
right to specific performance pursuant to Section 10 or any other rights that the Company may have under this Agreement or otherwise,
the Company shall have the right to terminate the payment of any remaining amounts to which Executive would otherwise be entitled pursuant
to Section 5(d)(i).

 

    6

     

    

 

(e) Board
and Officer Resignations. Upon termination of Executive’s employment hereunder for any reason, Executive shall be deemed to
have resigned, effective as of the date of such termination and to the extent applicable, from all Board or Officer positions held with
the Company and any affiliates of the Company.

 

(f) Executive’s
Continuing Obligations. Notwithstanding anything in this Agreement to the contrary, the termination of this Agreement and Executive’s
employment hereunder for any reason shall not terminate Sections 5(g), 6, 7, 8, 9, and 10 or Executive’s obligations thereunder,
each of which shall survive such termination.

 

(g) Assistance
by Executive. During any period in which any severance benefits are being paid to Executive under this Agreement after the date of
termination, Executive shall provide to the Company reasonable levels of assistance in answering questions concerning the business of
the Company, transition of responsibility, or litigation, provided that all out of pocket expenses Executive reasonably incurs in connection
with such assistance shall be fully and promptly reimbursed by the Company, and any such assistance shall not interfere or conflict with
the obligations which Executive may owe to any other employer.

 

6.
Confidential Information and Trade Secrets.

 

(a) Except
as set forth in Section 6(b), during Executive’s employment and perpetually after the termination of such employment, Executive:
(i) shall not communicate or divulge to any person, firm, corporation or business entity, either directly or indirectly, and shall hold
in strict confidence for the benefit of the Company, all Confidential Information and Trade Secrets (as defined below); and (ii) shall
not use any Confidential Information or Trade Secrets for Executive’s personal benefit, for the benefit of any third party or other
than in the course and within the scope of Executive’s employment with the Company.

 

(b) Notwithstanding
the foregoing, Executive may disclose such Confidential Information and Trade Secrets: (i) during the course of and within the scope of
Executive’s employment to persons, firms or corporations who have a legitimate need to know such Confidential Information or Trade
Secrets, including, but not limited to, the Company’s Affiliates;

(ii) as part of truthful testimony
in response to compulsory legal process; (iii) while participating or assisting in any investigation or inquiry by a governmental agency
acting within the scope of its statutory or regulatory jurisdiction; (iv) to a government official or to an attorney for the purpose of
reporting or investigating a suspected violation of law, in conformity with the Defend Trade Secrets Act; or (v) in a complaint or other
document filed in a lawsuit or other legal proceeding, so long as such filing is made under seal and in conformity with the Defend Trade
Secrets Act.

 

(c)
As used herein, “Confidential Information” means the whole or any portion or phase of any data or information
relating to the Company’s or an Affiliate’s business, services, products, solutions, processes or techniques (whether or
not copyrighted, patented or patentable) which: (i) has been disclosed to Executive orally or in writing or about which Executive
became or shall become aware as a consequence of, through or during Executive’s employment by the Company; (ii) has value to
the Company; and (iii) is not generally known by others; provided, however, that Confidential Information shall not include any
“Excluded Information,” as defined below. Confidential Information includes non-public regulatory filings with the Food
& Drug Administration, information describing patents in progress, etc.

 

    7

     

    

 

(d)
As used herein, “Trade Secrets” means: (i) any useful process, machine or other device or composition of matter
which is new or which Executive has a reasonable basis to believe may be new, and which is being used or studied by the Company or
its Affiliates and is not described in a patent or described in any literature already published and distributed externally by the
Company or its Affiliates; (ii) any software, data, design, plan, tool, process or method employed by the Company or its Affiliates,
whether patentable or not, which is not generally known to others; (iii) marketing plans and concepts; (iv) product development
plans and proposals; (v) financial information or projections regarding the Company or its Affiliates; (vi) financial, pricing
and/or credit information regarding clients, licensors or vendors of the Company or its Affiliates; (vii) a listing of names, postal
addresses, email addresses or telephone numbers of customers or clients of the Company or its Affiliates; (viii) contracts and other
legal documents belonging to the Company or its Affiliates; (ix) internal corporate policies and procedures of the Company or its
Affiliates; (x) any other information designated as a Trade Secret by the Company or its Affiliates at the time of its disclosure to
Executive; and (xi) any other information otherwise falling within the definition of a “Trade Secret” pursuant to the
Defend Trade Secrets Act and the Florida Uniform Trade Secrets Act, F.S. Section 688.001, et.seq.; provided, however, that
“Trade Secrets” shall not include any “Excluded Information,” as defined below. “Trade Secrets”
shall also include matters which have been disclosed to the Company by a third party which would otherwise fall within the foregoing
categories and with respect to which the Company owes a duty of confidentiality.

 

(e) As
used herein, “Excluded Information” means any data or information that Executive can establish is or was: (i) already
known to or otherwise in the possession of Executive when Executive received it from the Company or its Affiliates; (ii) publicly available
or otherwise in the public domain; (iii) rightfully obtained by Executive from a third party not under any obligation to the Company or
its Affiliates to maintain its secrecy and without breach of this Agreement by Executive; or (iv) independently developed by Executive
without use of Confidential Information or Trade Secrets.

 

(f) As
used herein, “Affiliates” means any person or entity that controls, directly or indirectly, the Company, and all persons
or entities that are controlled, directly or indirectly, by the Company, where control may be by management authority, equity interest
or otherwise.

 

7.
Non-Competition; Non-Solicitation.

 

(a) Executive
acknowledges that the Company and the Company’s Affiliates have a legitimate business interest in maintaining its customers and
goodwill. In light of the foregoing and as part of the consideration for Executive’s employment and the compensation now or hereafter
paid to Executive, Executive agrees as follows:

 

(i)
To the fullest extent permitted by law during the term of Executive’s employment with the Company under this Agreement, and
for the period of twenty-four (24) months after the date of termination of Executive’s employment under this Agreement for any
reason (the “Non-Compete Period”), Executive will not, directly or indirectly, participate in the ownership,
management, operation or control of, or work for or provide consulting services to, any person or entity that is engaged in, or
attempting to engage in, any line of business or project which, directly or indirectly, provides any of the services, products or
research the Company or the Company’s Affiliates provide, in any of the areas where the Company or the Company’s
Affiliates do business; provided, however, that this restriction applies only with respect to the Company’s Affiliates from
whom or with respect to which Executive received or had access to Confidential Information and Trade Secrets;

 

    8

     

    

 

(ii) During
the Non-Compete Period, Executive will not directly or indirectly, for Executive’s benefit or as an agent or Executive of any other
person or entity, solicit the employment or services of any Person Employed by the Company or the Company’s Affiliates, induce any
Person Employed by the Company or the Company’s Affiliates to leave his or her employment with the Company or the Company’s
Affiliates, or hire any Person Employed by the Company or the Company’s Affiliates. For purposes of this Section 7, the term “Person
Employed by the Company or the Company’s Affiliates” means any person who is or was an Executive of the Company at the
time of or within the twelve (12) months preceding the solicitation, inducement, or hiring; and

 

(iii) During
the Non-Compete Period, Executive will not, directly or indirectly, for Executive’s benefit or as an agent or Executive of any other
person or entity, solicit or induce any customers, distributors, vendors, licensors or suppliers of the Company or the Company’s
Affiliates with whom Executive had contact during Executive’s employment, or for whom Executive received Confidential Information
and Trade Secrets, to divert their business from the Company or the Company’s Affiliates to any other person or entity or in any
way interfere with the relationship between any such customer, distributor, vendor, licensor or supplier and the Company or the Company’s
Affiliates (including, without limitation, making any negative statements or communications about the Company or the Company’s Affiliates).

 

(b) Executive
understands that the provisions of Sections 6 and 7 of this Agreement may limit Executive’s ability to earn a livelihood in a business
similar to the business in which Executive is involved, but as an Executive member of the management group of the Company, Executive nevertheless
agrees and hereby acknowledges that: (i) such provisions do not impose a greater restraint than is necessary to protect the goodwill or
other legitimate business interests of the Company; (ii) such provisions contain reasonable limitations as to time, scope of activity,
and geographical area to be restrained; (iii) the consideration provided under this Agreement, including without limitation, any amounts
or benefits provided under Sections 4 or 5 of this Agreement, is sufficient to compensate Executive for the restrictions contained in
Section 6 and 7 of this Agreement; and (iv) the Company’s Affiliates are intended third party beneficiaries of the protections afforded
by Sections 6 and 7 of this Agreement.

 

(c)
In consideration of the foregoing and in light of Executive’s education, experience, skills and abilities, Executive agrees
that Executive will not assert that, and it should not be considered that, any provisions of Section 6 or 7 otherwise are void,
voidable or unenforceable or should be voided or held unenforceable. If, at the time of enforcement of Section 6 or 7 of this
Agreement, a court shall hold that the duration, scope, or area restrictions stated herein are unreasonable under circumstances then
existing, the parties hereto agree that the maximum period, scope or geographical area reasonable under such circumstances shall be
substituted for the stated period, scope or area and that the court shall be allowed and directed to revise the restrictions
contained herein to cover the maximum period, scope and area permitted by law.

 

    9

     

    

 

8.
Copyrightable Works.

 

(a) Executive
hereby acknowledges and agrees that each of the copyrightable works authored by Executive (including, without limitation, all bio-tech,
software and related documentation), alone or with others, during Executive’s employment by Company shall be deemed to have been
to be works prepared by Executive within the scope of Executive’s employment by Company. As such, Executive acknowledges and agrees
that all such copyrightable works shall be deemed to be “works made for hire” under the United States copyright laws from
the inception of creation of such works. To the extent possible, Executive waives any “moral rights” or other rights of attribution,
throughout the world.

 

(b) In
the event that any of such works shall be deemed by a court of competent jurisdiction not to be a “work made for hire,” this
Agreement shall operate as an irrevocable assignment by Executive to the Company of all right, title and interest in and to such works,
including, without limitation, all worldwide copyright interests therein, in perpetuity. Executive hereby assigns all right, title and
interest in and to any such works to the Company, including the right to sue for and recover damages for past infringement. The fact that
such copyrightable works are created by Executive outside of the Company’s facilities or other than during Executive’s working
hours with the Company shall not diminish the Company’s rights with respect to such works which otherwise fall within this paragraph.

 

(c) Executive
shall execute and deliver to the Company such further instruments or documents as may be requested by Company in order to effectuate the
purposes of this Section 8.

 

(d) Company
will not have claims on copyrightable works authored by Executive that are not related to Company business and are authored independently
thereof by Executive, e.g., works of fiction.

 

9.
Inventions.

 

(a) Executive
does not have any right, title or interest in, nor has Executive made or conceived, wholly or in part, prior to the execution of this
Agreement, any ideas, inventions, discoveries and improvements, except as disclosed on the attached Exhibit B.

 

(b)
All ideas, inventions, discoveries and improvements Executive makes or conceives, solely or with others, while employed by the
Company, where the subject matter of such ideas, inventions, discoveries and improvements results from or is suggested by any work
that Executive does for or on behalf of the Company or relates in any way to the Company’s products, services or businesses
(“Inventions”), shall belong to the Company, whether they are patentable or not. The fact that such Inventions
are made or conceived by Executive outside of the Company’s facilities or other than during Executive’s working hours at
the Company shall not diminish the Company’s rights with respect to such Inventions that otherwise fall within this
paragraph;

 

    10

     

    

 

(c) Executive
hereby assigns all right, title and interest it may possess in and to such Inventions to the Company or its nominee, including the right
to sue for and recover damages for past infringement and the right to claim priority to any applications filed that include those Inventions;

 

(d) At
the request of the Company, either during or after the termination of Executive’s employment under this Agreement, Executive shall
execute or join in executing all papers or documents required for the filing of patent applications in the United States and such foreign
countries as the Company may elect relating to Inventions covered by this Agreement, and Executive shall execute or join in executing
all papers or documents needed to assign all such patent applications to the Company or its nominee, and shall provide the Company or
its agents or attorneys with all reasonable assistance in the preparation and prosecution of patent applications, drawings, specifications
and the like, all at the expense of the Company, and shall do all that may be necessary to establish, protect and maintain the rights
of the Company or its nominee in such Inventions, patent applications, and Letters Patent in accordance with the spirit of this Agreement;
and

 

(e) In
the event Executive is unable or unwilling to execute any documents as reasonably required to protect the Company’s Inventions,
and to file copyright, patent, patent application and/or associated documents, Executive hereby irrevocably appoints the President of
the Company as Executive’s attorney to execute and deliver such documents on Executive’s behalf and in Executive’s name
and to do all other lawfully permitted acts to transfer the Inventions to the Company and further the transfer, issuance, prosecution
and maintenance of all intellectual property rights therein, to the fullest extent permitted by law. All such Inventions shall remain
the sole and exclusive property of the Company, whether patentable or not.

 

(f) Executive
shall execute and deliver to the Company such further instruments or documents as may be requested by the Company in order to effectuate
the purposes of this Section 9.

 

(g) Company
shall make no restrictions on Executive to list any such Invention, for which Executive was an Inventor or Co-Inventor, on Executive’s
curriculum vitae (CV) or biosketch, or for presentation or other purposes, provided that such Inventions are public knowledge.

 

10.
Injunction.

 

(a) In
the event of a breach or a threatened breach of the provisions in this Agreement, the Company shall be entitled to specific performance,
including, without limitation, an injunction restraining such breach, it being recognized that any injury arising from a breach would
be irreparable and would have no adequate remedy at law; however, nothing herein shall be construed as prohibiting the Company from enforcing
its rights under this Agreement (which are not intended to be exclusive) or from pursuing any other remedy available for such breach or
threatened breach at law or in equity.

 

    11

     

    

 

(b) In
addition, in the event of an alleged breach or violation by Executive of Section 6 of this Agreement, the Non-Compete Period set forth
therein shall be tolled until such breach or violation has been cured. In the event that an action is commenced due to an actual, alleged
or threatened breach of this Agreement, all costs of the dispute resolution contemplated by this Section 10 (including, without limitation,
the attorneys’ fees of the parties) shall be borne by the party who is the least successful in such dispute resolution, which shall
be determined by the court by comparing (i) the position asserted by each party on all disputed matters taken together to (ii) the final
decision of such presiding party on all disputed matters taken together.

 

11.
Choice of Law and Jurisdiction.

 

(a) This
Agreement shall be governed by, and construed in accordance with, the laws of the State of Florida, excluding choice of law principles.

 

(b) Executive
and Company consent to the exclusive jurisdiction of any state or federal court of competent jurisdiction located within Miami-Dade County
in the State of Florida, and Executive and Company irrevocably agree that all actions or proceedings relating to this Agreement may be
litigated in such courts. Executive and Company irrevocably waive any right to object to or challenge the above selected forum on the
basis of inconvenience or unfairness under 28 U.S.C. § 1404, or similar state or federal statutes.

 

12. Jury
Trial Waiver. To the extent permitted by law, the parties agree to, and do hereby, waive trial by jury in any action, proceeding,
or counterclaim brought by either of the parties against the other on any matter whatsoever arising out of or in any way connected with
this Agreement or the parties’ performance hereunder, or any claim of damage resulting from any act or omission of the parties,
or either of them, in any way connected with the Agreement.

 

13. Arbitration
of Disputes. Should any Dispute arise, such Dispute shall be resolved by the dispute resolution procedures set forth herein, which
procedures shall be exclusive and shall be final and binding.

 

(a) For
purpose of this Agreement, the term “Dispute” means: (i) a contention by either party that this Agreement has been breached;
(ii) a dispute as to the meaning or interpretation of this Agreement or any provision thereof; (iii) a dispute as to the validity or enforceability
of this Agreement or any provision thereof; or (iv) a contention that the Company or any of its affiliates or their Executives violated
any federal or state law (including common law) or statute regarding Executive’s employment, termination of employment, consideration
for continued employment, or wages or benefits. Notwithstanding the foregoing, any disagreement over whether something constitutes an
arbitrable Dispute shall be resolved by a court; the arbitrator shall not have jurisdiction to resolve such disputes unless the parties
mutually agree to submit that dispute to the arbitrator.

 

(b)
A Dispute shall be brought to the attention of the other party in writing within six (6) months of the date the material facts
giving rise to the Dispute first occurred. If the parties are unable to resolve the Dispute within thirty (30) days, the Dispute
shall be processed and resolved by the American Aribitraiton Association, using a single arbitrator in accordance with the National
Rules for the Resolution of Employment Disputes. The place of the arbitration shall be within 35 miles of the Company’s
principal place of business.

 

    12

     

    

 

(c) Notwithstanding
anything to the contrary in the National Rules for the Resolution of Employment Disputes, the Company shall pay the administrative and
arbitrator’s fees due to the American Arbitration Association and all Disputes shall be processed on an individual basis between
only the parties to this Agreement and not on a class, collective, private attorney general, or other representative basis absent mutual
consent of the Parties.

 

(d) Nothing
in this Agreement prohibits Executive from filing charges against the Company or with any federal, state, or local agency; however, Executive
shall inform the agency of this Agreement if the underlying dispute or claim constitutes a Dispute.

 

 (e) Disputes DO NOT INCLUDE the following types of claims and disputes:

 

ii. Claims seeking workers’ compensation
or unemployment compensation benefits;

 

ii. Claims seeking benefit under an Executive
benefit plan that provides its own claim procedures;

 

iii. Claims
seeking equitable relief relating to the alleged breach of a restrictive covenant or confidentiality agreement or the alleged misappropriation
of trade secrets; and

 

iv. Any other claims that, as a matter of law,
the parties cannot agree to arbitrate.

 

14. Company
Property. All rights, title and interest in all records, documents or files concerning the business of the Company, including,
but not limited to, customer data, materials, processes, letters, Trade Secrets and Confidential Information, or other written or electronically
recorded material, whether or not produced by Executive, shall be and remain the property of the Company. Upon termination of employment,
Executive shall not have the right to remove any such records from the offices or premises of the Company even if such records are commingled
with Executive’s personal records, although nothing herein prohibits Executive from removing his personal hard copy and electronic
records that do not contain Trade Secrets and Confidential Information. In addition, Executive agrees to conduct a reasonably diligent
search and return promptly to the Company all things of whatsoever nature that belong to the Company and all records (in whatsoever form,
format or medium) containing or related to Trade Secrets and Confidential Information. If, following the termination of employment and
a reasonably diligent search, Executive finds that he has inadvertently retained in his possession any things that belong to the Company
or records containing or related to Trade Secrets and Confidential Information, then he shall promptly return same.

 

15. Separateness;
Construction. It is a desire and intent of the parties that the terms, provisions, covenants, and remedies contained in this
Agreement shall be enforceable to the fullest extent permitted by law. If any provision or clause of this Agreement, or portion
thereof shall be held by any court or other tribunal of competent jurisdiction to be illegal, invalid, or unenforceable in such
jurisdiction, the remainder of such provision shall not be thereby affected and shall be given full effect, without regard to the
invalid portion. It is the intention of the parties that, if any court construes any provision or clause of this Agreement, or any
portion thereof, to be illegal, void or unenforceable because of the duration of such provision or the area or matter covered
thereby, such court shall reduce the duration, area, or matter of such provision, and, in its reduced form, such provision shall
then be enforceable and shall be enforced.

 

    13

     

    

 

16. Entire
Agreement. This Agreement and the attachments contain the entire agreement between the parties pertaining to the terms of Executive’s
employment, non- competition, trade secrets and confidential documents and information of the Company. No modification thereof shall be
binding upon the parties unless the same is in writing signed by the respective parties.

 

17. Representations
and Warranties. Executive hereby represents, warrants and agrees that: (a) Executive has the full power to enter into this Agreement
and perform the services required of Executive as an Executive of the Company, without any restriction whatsoever; (b) in the course of
performing services as an Executive of the Company, Executive will not violate the terms or conditions of any agreement between Executive
and any third party or infringe or wrongfully appropriate any patents, copyrights, trade secrets or other intellectual property rights
of any person or entity anywhere in the world; (c) Executive has not and will not disclose or use during his employment by the Company
any confidential information that Executive acquired as a result of any previous employment or consulting arrangement or under a previous
obligation of confidentiality; and (d) Executive has disclosed to the Company in writing any and all continuing obligations to others
that require Executive not to disclose any information to the Company.

 

18. Assignment.
This Agreement shall be binding upon and inure to the benefit of the Company, its successors in interest, or any other person, association,
or entity which may hereafter acquire or succeed to all or substantially all of the business assets of the Company by any means, whether
indirectly or directly, and whether by purchase, merger, consolidation, or otherwise. No such assignment shall relieve Executive of any
of Executive’s obligations under this Agreement. Executive’s rights and obligations under this Agreement are personal and
such rights, benefits, and obligations of Executive shall not be voluntarily or involuntarily assigned, alienated, or transferred by Executive,
whether by operation of law or otherwise, without the prior written consent of the Company, except that any amounts owed by Company to
Executive in the event of Executive’s death or Disability must be paid to Executive’s personal representative, guardian, or
as otherwise directed by Executive’s estate plan.

 

19. Waiver.
No failure by either party hereto at any time to give notice of any breach by the other party of, or to require compliance with, any condition
or provision of this Agreement shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior
or subsequent time.

 

20. Construction.
The essential terms and conditions contained in this Agreement have been mutually negotiated between the parties hereto. No
ambiguity in this instrument shall be construed or interpreted as against the drafter of this Agreement, as each party contributed
to drafting of the provisions hereof.

 

    14

     

    

 

21.
Code Section 409A.

 

(a) General.
The intent of the parties is that the payments and benefits under this Agreement comply with or be excepted from Section 409A of the
Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively, “Section
409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance
therewith. Each payment under this Agreement, including each installment payment, shall be considered a separate and distinct
payment. For purposes of this agreement, each payment is intended to be excepted from Section 409A to the maximum extent provided as
follows: (i) each payment made within the applicable 21⁄2 month period specified in Treas. Reg. § 1.409A-1(b)(4) is
intended to be excepted under the short-term deferral exception; (ii) post-termination medical benefits are intended to be excepted
under the medical benefits exceptions as specified in Treas. Reg. § 1.409A-1(b)(9)(v)(B); and (iii) to the extent payments are
made as a result of an involuntary separation, each payment that is not otherwise excepted under the short-term deferral exception
or medical benefits exception is intended to be excepted under the involuntary pay exception as specified in Treas. Reg. §
1.409A-1(b)(9)(iii). With respect to any payment subject to Section 409A (and not excepted therefrom), if any, it is intended that
each payment is paid on a permissible distribution event and at a specified time consistent with Section 409A. The Executive shall
have no right to designate the date of any payment under this Agreement. Except as otherwise permitted under Section 409A, no
payment hereunder shall be accelerated or deferred unless such acceleration or deferral would not result in additional tax or
interest pursuant to Section 409A.

 

(b) Separation
from Service. Notwithstanding anything in this Agreement to the contrary, any compensation or benefits payable under this Agreement
that is designated under this Agreement as payable upon Executive’s termination of employment shall be payable only upon Executive’s
“separation from service” with the Company and all of its controlled group members within the meaning of Section 409A and
Treas. Reg. § 1.409A-1(h). Whether Executive has a separation from service will be determined based on all of the facts and circumstances
and in accordance with the guidance issued under Section 409A.

 

(c) Specified
Executive. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the Company at the time of
Executive’s Separation from Service to be a “specified Executive” for purposes of Section 409A, to the extent delayed
commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited
distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of
(i) the expiration of the six-month period measured from the date of Executive’s Separation from Service with the Company or (ii)
the date of Executive’s death. Upon the first business day following the expiration of the applicable Section 409A period, all payments
deferred pursuant to the preceding sentence shall be paid in a lump sum to Executive (or Executive’s estate or beneficiaries), and
any remaining payments due to Executive under this Agreement shall be paid as otherwise provided herein.

 

    15

     

    

 

(d) Expense
Reimbursements. Except as otherwise expressly provided herein, all taxable reimbursements of expenses, in-kind benefits and/or cash
allowances/premiums provided or paid by the Company to the Executive under this Agreement shall be made in accordance with and subject
to the following terms and conditions: (i) reimbursements shall only be made to the extent that the expense was actually incurred and
reasonably substantiated; (ii) no reimbursement of any expense incurred in one taxable year will affect the amount available for reimbursement
in any other taxable year; (iii) reimbursements of eligible expenses shall be made on or before the last day of the Executive’s
taxable year following the taxable year in which the expense was incurred; and (iv) the right to reimbursement shall not be subject to
liquidation or exchange for another benefit. To the extent required by applicable law, the Company will annually report as taxable wages
and/or impute income to the Executive the value of any taxable benefits and/or payments to the Executive.

 

(e) Acknowledgement.
Notwithstanding any provision of this Agreement to the contrary, Executive acknowledges and agrees that the Company and its Executives,
officers, directors, subsidiaries and affiliates shall not be liable for, and nothing provided or contained in this Agreement will be
construed to obligate or cause the Company and/or its Executives, officers, directors, subsidiaries and affiliates to be liable for, any
tax, interest or penalties imposed on Executive related to or arising with respect to any violation of Section 409A.

 

[Remainder of Page Intentionally
Left Blank]

[Signature Page Follows]

 

    16

     

    

 

IN WITNESS WHEREOF, the parties have
entered into this Agreement as of the date set forth above.

 

	Longeveron, Inc.	 
	 	 	 
	By:	/s/ Geoff Green	 
	Name: 	Geoff Green	 
	Title:	CEO	 
	Date:	4/4/2022	 
	 	 	 
	By:	/s/ Chris Min	 
	Name:	Chris Min, M.D., PhD	 
	Date:	4/4/2022	 

 

    17

     

    

 

EXHIBIT A

 

FORM OF RELEASE

 

SEPARATION AGREEMENT AND GENERAL RELEASE

 

This Separation Agreement and General
Release (“Agreement”) is between Longeveron, Inc. (“Company”) and Geoff Green (“Executive”),
together the “Parties.”

 

WHEREAS, the Company terminated
Executive’s employment on   (“Termination Date”);

 

WHEREAS, the Company is
willing to pay Executive certain severance in exchange for a release of claims and other commitments.

 

NOW THEREFORE, intending to
be legally bound and for good and valuable consideration, Company and Executive agree as follows:

 

 1. Recitals. The foregoing recitals are true and correct and incorporated herein.

 

2.
Termination of Employment.

 

(a) The
Company timely paid or will timely pay Executive, in accordance with its normal payroll and other procedures (or as otherwise required
by law), for (i) Executive’s work through the Termination Date, (ii) Executive’s accrued but unused vacation pay, and

(iii) Executive’s
properly reported and reimbursable business expenses, less all required tax withholdings and other deductions.

 

(b)
Executive’s eligibility to participate in the Company’s group insurance and other welfare benefit plans and programs ceased
as of the Termination Date, except that Executive’s group insurance medical benefits ceased or will cease on______________, unless otherwise
extended under COBRA.

 

(c) The
foregoing payments and benefits have been or will be provided to Executive regardless of whether Executive signs or revokes this Agreement.

 

3.
Severance Benefits.

 

(a)
The Company will pay Executive severance in an amount equal to ( ) months of Executive’s then existing annual Base Salary
(excluding bonuses, commissions, incentive payments and any other form of supplemental compensation) (a total of $ )
(“Severance”), and any earned bonus for the year that has yet to be paid out, less all required tax withholdings
and other deductions. Company will pay the Severance to Executive within fourteen (14) days after this Agreement becomes effective
(as described below), but in no event later than the sixtieth (60th) day following the Termination Date.

 

    1

     

    

 

(b)
If Executive timely elects to continue Executive’s group health benefits under COBRA, the Company will reimburse Executive, upon
presentment of satisfactory proof of payment, the amount of Executive’s paid COBRA premiums for_______________( ) months.1

 

4.
Release of Claims.

 

(a) Executive,
on behalf of Executive and Executive’s heirs and personal representatives, hereby releases and forever discharges the Company, its
direct and indirect subsidiaries, divisions, parents, affiliates, companies under common control of any of the foregoing, predecessors,
successors, and assigns, and its and their past, present and future shareholders, partners, principals, managers, members, directors,
officers, Executives, agents, attorneys, insurers, Executive benefit plans, trustees and all others acting in concert with them (collectively,
the “Released Parties”), from any and all claims, actions, suits, proceedings, complaints, causes of action, grievances,
debts, costs and expenses (including attorney’s fees), at law or in equity, known or unknown, suspected or unsuspected, whether legal
or equitable, fixed or contingent, liquidated or un-liquidated, asserted or un-asserted, whether based in common law, statute, contract,
warranty, tort or otherwise, that Executive has or may have through the date Executive signs this Agreement, arising out of, based on,
or relating in any way to any acts or omissions that occurred, in whole or in part, prior to the time that Executive signs this Agreement,
including, but not limited to, claims that arise out of, result from, or are in any manner related to Executive’s employment with
the Company or separation from the Company, claims that arise out of, result from, or are in any manner related to the negotiation and
execution of this Agreement, claims for wages, salary, commission, Executive benefits, vacation pay or other paid time off, severance
pay, pension or profit sharing benefits, health or welfare benefits, bonus compensation, commissions, deferred compensation or other remuneration
arising out of the employment relationship with the Company, claims for breach of any express or implied contract, wrongful termination,
retaliation, invasion of privacy, negligence, gross negligence, misrepresentation, express or implied duty of good faith and fair dealing,
fraud, refusal to perform an illegal act, whistleblower, malicious prosecution, abuse of process, defamation of character, personal injury,
intentional or negligent infliction of emotional distress, discrimination, retaliation or harassment based on race, religion, sex, marital
status, genetic information, sexual stereotypes, gender identity, age, color, handicap and/or disability, national origin or any other
protected class and any other claim based on or related to Executive’s employment with the Company or Executive’s departure therefrom,
including, but not limited to, claims for violation of the Executive Retirement Income Security Act of 1974, Title VII of the Civil Rights
Act of 1964, the Age Discrimination in Employment Act of 1967, the Older Workers’ Benefit Protection Act of 1990, the Americans
with Disabilities Act, the Americans With Disabilities Act Amendments Act, the Worker Adjustment and Retraining Notification Act, the
Equal Pay Act of 1963 as amended, the Ledbetter Fair Pay Act, the Civil Rights Acts of 1866, 1871 and 1991, the Immigration Reform and
Control Act, the Rehabilitation Act of 1973, the Occupational Safety and Health Act of 1970, the Fair Credit Reporting Act, the Family
and Medical Leave Act, the False Claims Act, the Florida Civil Rights Act of 1992, the Florida Whistleblower
Act (Fla. Stat. §448.101-448.105), the Florida Constitution, the Florida False Claims Act, the Florida Workers Compensation Retaliation
Statute (Fla. Stat. §440.205), the Florida Wage Discrimination Law (Fla. Stat. §448.07), the Florida Equal Pay Law, the Florida
AIDS Act (Fla. Stat. §§110.125, 381.00 and 760.50), Florida OSHA (Fla. Stat. §442.018(2)), Florida Wage Payment Laws, Florida
Discrimination on the Basis of Sickle Cell Trait Law, the Florida Family and Medical Leave Act, and any other international, federal,
state or local law, ordinance, Executive order, code, rule, regulation, or statute, all as amended.

  

 

		1	Be aware that if you cancel COBRA coverage in the future, then
that may be deemed a voluntary relinquishment (and not a “qualifying event”) and, if so, this can delay the time when you could
acquire coverage through an Affordable Care Act marketplace plan.

    2

     

    

 

(b) Notwithstanding
anything in this Agreement to the contrary, the release set forth in Section 4(a) does not and is not intended to release any claims that
cannot be released by law, such as claims for vested pension benefits or claims for workers’ compensation benefits, or release any rights
to a defense or indemnification from the Company or its insurers for actions Executive took or failed to take during the course of Executive’s
employment with the Company.

 

(c)
Notwithstanding anything in this Agreement to the contrary, the release set forth in Section 4(a) does not and is not intended to
prevent, restrict or otherwise interfere with Executive’s right to (i) file a charge or complaint with any appropriate federal,
state or local agency or court, (ii) testify, assist, participate in, or cooperate with the investigation of any charge or complaint
pending before or being investigated by such agency or court, (iii) enforce this Agreement, (iv) seek a judicial determination of
the validity of the release of Executive’s rights under the Age Discrimination in Employment Act, or (v) report violations of any
law administered by the Securities and Exchange Commission (“SEC”) or Occupational Safety and Health
Administration (“OSHA”), receive any financial awards from the SEC or OSHA for reporting possible violations of
federal law or regulation, or make other disclosures protected under the whistleblower provisions of state or federal law or
regulation.

 

(d) If
an administrative agency or court assumes jurisdiction over any charge or complaint involving claims that are released by Section 4(a)
of this Agreement, Executive hereby agrees to not, directly or indirectly, accept, recover or receive any resulting monetary damages or
other equitable relief that otherwise would be due, and Executive hereby expressly waives any rights to any such recovery or relief, except
as permitted by Section 4(c)(v).

 

5.
Time Limits, Revocation and Effective Date.

 

(a) Executive
acknowledges and agrees that Executive received this Agreement on the Termination Date. Executive has up to twenty-one (21) days from
the date Executive received this Agreement to consider its terms. Any changes to this Agreement during that period, whether material or
not, will not extend the 21-day period. If Executive signs this Agreement, Executive may still revoke Executive’s acceptance of the Agreement
for up to seven (7) days after Executive signs it, by notifying the Company in writing before the expiration of that seven-day period.
The written notice should be delivered in person or, if sent by mail, postmarked no later than the 7th day and mailed to:

 

[Insert
name and address.]

 

(b) If not revoked,
this Agreement will become effective on the 8th day after Executive signs it. If Executive does not sign this Agreement within the
21-day period, or if Executive timely revokes this Agreement during the seven-day revocation period, this Agreement will not become
effective and Executive will not be entitled to the Severance Benefits provided for in Section 3.

 

    3

     

    

 

6. Consult
with an Attorney. The Company hereby advises Executive to consult with an attorney of Executive’s choice (at Executive’s expense)
before Executive signs this Agreement. The Company will rely on Executive’s signature on this Agreement as Executive’s representation
that Executive read this Agreement carefully before signing it, and that Executive has a full and complete understanding of its terms.

 

7. Representations.
By signing below, Executive represents and agrees that the following are true and correct to the best of Executive’s knowledge:

 

(a) Except
for the wages and benefits to be paid to Executive regardless of whether Executive signs this Agreement, as described in Section 2, the
Severance Benefits to be paid under this Agreement, and any vested pension benefits Executive may be entitled to receive, the Company
does not owe Executive any other wages, compensation, or benefits of any kind or nature;

 

(b) The
Company has provided Executive with all leave to which Executive was entitled and, to the best of Executive’s knowledge, Executive is
not suffering from any work- related injuries;

 

(c) Executive has not received, is not receiving,
and has not applied for Medicare:

 

(d) Executive has notified the Company of any
charge or complaint Executive filed with any agency or court that is still pending before such court or agency;

 

(e) The
Severance Benefits described in Section 3 are things that Executive is not entitled to receive in the absence of this Agreement;

 

(f) Executive
has returned to the Company all property and information that belongs to the Company, including, but not limited to the following (where
applicable): automobile; computers (desktop and laptop); phone; tablet; iPad; devices (including usb, external hard drives, etc.); handheld
devices; keys, access cards, passwords, and/or ID cards; all electronically stored and paper copies of all financial data, customer information,
business plans and reports, and Company files; and all records, customer lists, written information, forms, plans, and other documents,
including electronically stored information. Executive shall search Executive’s electronic devices, device back-ups, residence, and automobile
and agrees that by signing below, Executive has disclosed all Company property in Executive’s possession or control and returned such
property as directed by Company; and

 

(g) Executive
has not asserted any claim for sexual harassment or sexual abuse by any of the Released Parties and is not aware of any facts supporting
such a claim.

 

    4

     

    

 

(h) Executive
is not aware of any violations of the law or Company agreements or policies, and is not aware of wrongdoing by the Company or its officers,
including any alleged corporate fraud, that should be reported to authorities.

 

(i) Executive
hereby voluntarily resigns as an Officer and/or Director of the Company or any Released Party effective as of the Termination Date.

 

8. No
Re-employment. Executive acknowledges and agrees that he shall not knowingly re-apply for employment with the Released Parties,
nor will Executive knowingly accept any employment or otherwise work for the Released Parties. Further, Executive agrees that his forbearance
to seek future employment with the Released Parties is purely contractual and is in no way involuntary, discriminatory, retaliatory, or
in violation of any contract or policy of the Released Parties. If Executive applies for employment with the Released Parties, the Released
Parties are not under any obligation to process or otherwise act upon such application.

 

9. Confidentiality.
Executive will keep this Agreement and its terms (other than the fact that Executive was terminated on the Termination Date)
confidential and will not disclose such information to anyone other than Executive’s immediate family and professional advisors,
each of whom must, as a condition to the disclosure, agree to keep the information confidential. Executive will be responsible for
any breach of this Section by Executive’s immediate family members and professional advisors. Notwithstanding the foregoing, this
Agreement does not prohibit Executive from (a) providing truthful testimony in response to compulsory legal process, (b)
participating or assisting in any investigation or inquiry by a governmental agency acting within the scope of its statutory or
regulatory jurisdiction, or (c) making truthful statements in connection with any claim permitted to be brought by Executive under
Sections 4(b) or (c).

 

10.
Confidential Information.

 

(a) Executive
will not disclose to any third parties any of the trade secrets and other confidential proprietary information of the Company, including,
but not limited to, information regarding the Company’s operations, products, services, suppliers, customers, research, development, new
products, marketing, marketing plans, business plans, budgets, finances, licenses, prices, and costs (“Confidential Information”)
without the express written consent of the Company, which consent may be withheld by the Company in its sole and absolute discretion.
Notwithstanding the foregoing, this Agreement does not prohibit Executive from disclosing Confidential Information (i) as part of truthful
testimony in response to compulsory legal process, (ii) while participating or assisting in any investigation or inquiry by a governmental
agency acting within the scope of its statutory or regulatory jurisdiction, (iii) to a government official or to an attorney for the purpose
of reporting or investigating a suspected violation of law, in conformity with the Defend Trade Secrets Act, or (iv) in a complaint or
other document filed in a lawsuit or other legal proceeding, so long as such filing is made under seal and in conformity with the Defend
Trade Secrets Act.

 

(b) Executive’s
obligations under this Section include, but are not limited to, any and all Confidential Information the Company provided to Executive,
Executive developed on behalf of the Company, or to which Executive had access, as well as information third parties provided to the Company
that the Company is obligated to keep confidential.

 

    5

     

    

 

11.
Applicable Law; Jurisdiction and Venue.

 

(a) This
Agreement shall be governed by and construed in accordance with the laws of the State of Florida, without giving effect to the principles
of conflicts of law.

 

(b) The
Parties consent to the exclusive jurisdiction of any state or federal court of competent jurisdiction located within Miami-Dade County
in the State of Florida, and irrevocably agree that all actions or proceedings relating to this Agreement may be litigated in such courts.
The Parties irrevocably waive any right to object to or challenge the above selected forum on the basis of inconvenience or unfairness
under 28 U.S.C. § 1404 or similar state or federal statutes.

 

12. Entire
Agreement; Other Agreements. This Agreement contains the entire agreement of the parties with respect to the subject matter hereof,
and no representation, promise, or agreement, oral or written, relating hereto that is not contained herein shall be of any force or effect.
Moreover, if Executive entered in any other enforceable agreements with the Company that contain provisions that are not in direct conflict
with the provisions of this Agreement, those other agreements shall remain in effect and the terms of this Agreement shall be in addition
to such other such agreements.

 

13. No
Disparagement. Neither Party will make any intentionally defamatory or intentionally disparaging statements to any third parties
regarding the other, its services, or any of its Executives, officers, or owners. Notwithstanding the foregoing, this Agreement does not
prohibit either party from (a) providing truthful testimony in response to compulsory legal process,

(b) participating or assisting
in any investigation or inquiry by a governmental agency acting within the scope of its statutory or regulatory jurisdiction, or (c) making
truthful statements in connection with any claim permitted to be brought by Executive under Sections 4(b) or (c).

 

14. No
Admissions. Neither the execution of this Agreement nor the performance of its terms and conditions shall be construed or considered
by any party or by any other person as an admission of liability or wrongdoing by either party.

 

15. Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be considered an original instrument and all of which together
will be considered one and the same agreement and will become effective when all executed counterparts have been delivered to the respective
parties. Delivery of executed pages by facsimile transmission or e-mail will constitute effective and binding execution and delivery of
this Agreement.

 

16. Assignment.
This Agreement shall be binding upon and shall inure to the benefit of the Company and its respective successors and assigns, and any
such successors and assigns shall be considered third-party beneficiaries of this Agreement. Executive has no rights to assign this Agreement.

 

17. Acknowledgements.
Executive hereby acknowledges that Executive (a) has read this Agreement and understands all of its provisions; and (b) voluntarily enters
into this Agreement, which is contractual in nature and contains a general release of claims.

 

    6

     

    

 

18. Severability.
If any term, provision or Section of this Agreement is determined by a court of competent jurisdiction to be invalid or unenforceable
for any reason, such determination shall be limited to the narrowest possible scope in order to preserve the enforceability of the remaining
portions of the term, provision or Section, and such determination shall not affect the remaining terms, provisions or paragraphs of this
Agreement, which shall continue to be given full force and effect.

 

19. 409A.
The provisions of this Agreement will be administered, interpreted and construed in a manner intended to comply with Section 409A of the
Internal Revenue Code of 1986, as amended, the regulations issued thereunder, or any exception thereto (or disregarded to the extent such
provision cannot be so administered, interpreted, or construed). Each payment under this Agreement shall be considered a separate and
distinct payment. Executive shall have no right to designate the date of any payment under this Agreement. Nothing contained in this Agreement
shall constitute any representation or warranty by the Company regarding compliance with Section 409A. The Company has no obligation to
take any action to prevent the assessment of any tax under Section 409A on any person and neither the Company, nor its subsidiaries or
affiliates, nor any of their Executives, officers, directors or other representatives shall have any liability to Executive with respect
thereto.

 

20. Further
Assurances. Executive and the Company each agree to execute and deliver, after the date hereof, without additional consideration,
any additional documents, and to take any further actions, as may be necessary to fulfill the intent of this Agreement and the transactions
contemplated hereby.

 

21.
Cooperation.

 

(a) Executive
will (i) cooperate with the Company in all reasonable respects concerning any transitional matters which require Executive’s assistance,
cooperation or knowledge, including communicating with persons inside or outside the Company as directed by the Company, and (ii) in the
event that the Company (or any of its affiliates or other related entities) becomes involved in any legal action relating to events which
occurred during Executive’s employment with the Company, cooperate to the fullest extent reasonably possible in the preparation, prosecution
or defense of their case, including, but not limited to, the execution of affidavits or documents, testifying or providing information
requested by the Company. Notwithsdanding the foregoing, Executive is not required to cooperate to the extent such cooperation would interfere
or conflict with the obligations which Executive may owe to any other employer.

 

(b) To
the extent that Executive incurs (i) travel-related expenses, (ii) out-of- pocket expenses, and/or (iii) loss of wages as a result of
Executive’s cooperation with the Company as contemplated by this Section 21 (“Cooperation Expenses”), the Company will
promptly reimburse Executive (or will cause Executive to be promptly reimbursed) for such Cooperation Expenses, provided they are reasonable
and were approved by the Company in advance.

 

    7

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Agreement on the date(s) set forth below.

 

	Longeveron Inc.	 
	 	 	 
	By	          	 
	Name	 	 
	Title	 	 
	Date	 	 
	  	 	 
	 	 	 

	Chris Min	 	 
	Date	 	 

 

    8

     

    

 

EXHIBIT B

 

EXECUTIVE’S
PRIOR INVENTIONS

 

 

 

 

 

 

 

 

 

 

 

 

9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]